Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve Cap
18 janv. 2024 17h00 HE
|
Axogen, Inc.
REPOSE® met its primary endpoint of non-inferiority between the pain visual analog scale outcomes for neurectomy with Axoguard Nerve Cap® vs. standard-of-care neurectomy at Month 12. Axoguard Nerve...
Olema Oncology Reports Third Quarter 2023 Financial Results and Provides Corporate Update
07 nov. 2023 16h02 HE
|
Olema Oncology
OPERA-01 pivotal Phase 3 monotherapy clinical trial on track, with clinical site activation ongoing and first patient expected to be enrolled in fourth quarterNew clinical data for palazestrant...
Axogen to Participate at Upcoming Investor Conferences
31 août 2023 07h00 HE
|
Axogen, Inc.
ALACHUA and TAMPA, Fla., Aug. 31, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today...
[Latest] Global Women’s Health Diagnostics Market Size/Share Worth USD 45.4 Billion by 2032 at a 7.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
18 juil. 2023 04h30 HE
|
Custom Market Insights
Austin, TX, USA, July 18, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Women’s Health Diagnostics Market Size, Trends and Insights By Application...
AccuStem Sciences, Inc. Extends and Broadens Partnership with Instituto Europeo di Oncologia (IEO) Enabling its Strategic Approach to Address Unanswered Clinical Questions in Early Stage Breast Cancer
11 juil. 2023 07h00 HE
|
AccuStem Sciences, Inc
StemPrintER outperformed the current market leader, OncotypeDX test, in stratifying patients according to their risk of breast cancer recurrence LONDON and PHOENIX, July 11, 2023 (GLOBE NEWSWIRE)...
Cancer Biomarkers Market revenue to cross USD 33 Billion by 2033, says Research Nester
05 juil. 2023 08h11 HE
|
Research Nester
New York, July 05, 2023 (GLOBE NEWSWIRE) -- The global cancer biomarkers market is estimated to grow at a CAGR of ~14% from 2023 to 2033. The market is estimated to garner a revenue of nearly USD 33...
Global Cancer Stem Cells Market Predicted to Register a Revenue of $1,722.7 Million and Grow at a CAGR of 10.3% Over the Estimated Timeframe 2019-2026 [180-Pages] | Released by Research Dive
12 avr. 2023 09h02 HE
|
Research Dive
New York, USA, April 12, 2023 (GLOBE NEWSWIRE) -- According to a report published by Research dive, the global cancer stem cells market is anticipated to garner $1,722.7 million in revenue and rise...
NovaScan’s nsCanary™ Tech Platform Named One of Five Finalists in AGA’s Shark Tank Competition
02 mars 2023 10h00 HE
|
NovaScan
Chicago, IL, March 02, 2023 (GLOBE NEWSWIRE) -- NovaScan, a clinical stage oncology company, has been selected by the American Gastroenterological Association (AGA) as a finalist in its annual Shark...
[Latest] Global Breast Cancer Diagnostics Market Size/Share Worth USD 7.5 Billion by 2030 at a 6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
01 févr. 2023 15h30 HE
|
Custom Market Insights
Sandy, Utah, USA, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Breast Cancer Diagnostics Market Size, Trends, and Insights By Type (Imaging,...
Mastopexy Market is set to exceed US$ 2,175 Mn by 2030 - Exclusive Report By Acumen Research And Consulting
30 mai 2022 14h19 HE
|
Acumen Research and Consulting
NEW YORK, May 30, 2022 (GLOBE NEWSWIRE) -- The global mastopexy market size is projected to arrive at a value of around USD 2,175 Million by 2030, with a CAGR of above 5.8% from 2022 to 2030. ...